Impact of bevacizumab in combination with erlotinib on <scp><i>EGFR</i></scp>‐mutated non–small cell lung cancer xenograft models with <scp>T790M</scp> mutation or <scp><i>MET</i></scp> amplification
Distribution of the number of citations over years.